Hong-Qiang Wang

Hong-Qiang Wang


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2011 in IEEE Transactions on Nanobioscience
Verified
Journal Article
Closed access
CZChun-Hou Zheng
Chun-Hou Zheng
TNTo-Yee Ng
To-Yee Ng
LZLei Zhang
Lei Zhang
CSChi-Keung Shiu
Chi-Keung Shiu
HWHong-Qiang Wang
Hong-Qiang Wang
This paper presents a new method for tumor classification using gene expression data. In the proposed method, we first select genes using nonnegative matrix factorization (NMF) or sparse NMF (SNMF), and then we extract features from the selected genes by virtue of NMF or SNMF. At last, we apply support vector machines (SVM) to classify the tumor samples using the extracted features. In order for a better classification, a modified SNMF algorithm is also proposed. The experimental results on benchmark three microarray data sets validate that the proposed method is efficient. Moreover, the biological meaning of the selected genes are also analyzed.


22 January 2023 in Molecules
Verified
Journal Article
Open access
PDF file
Lei HuLei Hu
Lei Hu
YLYu Liu
Yu Liu
CFChangfang Fu
Changfang Fu
JZJiarong Zhao
Jiarong Zhao
QQqianwencui qianwencui
qianwencui qianwencui
WYWulin Yang
Wulin Yang
The oncogenic role of Ladinin-1 (LAD1), an anchoring filament protein, is largely unknown. In this study, we conducted a series of studies on the oncogenic role of LAD1 in lung adenocarcinoma (LUAD). Firstly, we analyzed the aberrant expression of LAD1 in LUAD and its correlation with patient survival, tumor immune infiltration, and the activation of cancer signaling pathways. Furthermore, the relationship between LAD1 expression and K-Ras and EGF signaling activation, tumor cell proliferation, migration, and colony formation was studied by gene knockout/knockout methods. We found that LAD1 was frequently overexpressed in LUAD, and high LAD1 expression predicts a poor prognosis. LAD1 exhibits promoter hypomethylation in LUAD, which may contribute to its mRNA upregulation. Single-sample gene set enrichment analysis (ssGSEA) showed that acquired immunity was negatively correlated with LAD1 expression, which was verified by the downregulated GO terms of “Immunoglobulin receptor binding” and “Immunoglobulin complex circulating” in the LAD1 high-expression group through Gene Set Variation Analysis (GSVA). Notably, the Ras-dependent signature was the most activated signaling in the LAD1 high-expression group, and the phosphorylation of downstream effectors, such as ERK and c-jun, was strongly inhibited by LAD1 deficiency. Moreover, we demonstrated that LAD1 depletion significantly inhibited the proliferation, migration, and cell-cycle progression of LUAD cells and promoted sensitivity to Gefitinib, K-Ras inhibitor, and paclitaxel treatments. We also confirmed that LAD1 deficiency remarkably retarded tumor growth in the xenograft model. Conclusively, LAD1 is a critical prognostic biomarker for LUAD and has potential as an intervention target.

23 October 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HWHong-Qiang Wang
Hong-Qiang Wang
CTChung-Jui Tsai
Chung-Jui Tsai
With the rapid increase of omics data, correlation analysis has become an indispensable tool for inferring meaningful associations from a large number of observations. Pearson correlation coefficient (PCC) and its variants are widely used for such purposes. However, it remains challenging to test whether an observed association is reliable both statistically and biologically. We present here a new method, CorSig, for statistical inference of correlation significance. CorSig is based on a biology-informed null hypothesis, i.e., testing whether the true PCC (ρ) between two variables is statistically larger than a user-specified PCC cutoff (τ), as opposed to the simple null hypothesis of ρ = 0 in existing methods, i.e., testing whether an association can be declared without a threshold. CorSig incorporates Fisher's Z transformation of the observed PCC (r), which facilitates use of standard techniques for p-value computation and multiple testing corrections. We compared CorSig against two methods: one uses a minimum PCC cutoff while the other (Zhu's procedure) controls correlation strength and statistical significance in two discrete steps. CorSig consistently outperformed these methods in various simulation data scenarios by balancing between false positives and false negatives. When tested on real-world Populus microarray data, CorSig effectively identified co-expressed genes in the flavonoid pathway, and discriminated between closely related gene family members for their differential association with flavonoid and lignin pathways. The p-values obtained by CorSig can be used as a stand-alone parameter for stratification of co-expressed genes according to their correlation strength in lieu of an arbitrary cutoff. CorSig requires one single tunable parameter, and can be readily extended to other correlation measures. Thus, CorSig should be useful for a wide range of applications, particularly for network analysis of high-dimensional genomic data. A web server for CorSig is provided at http://202.127.200.1:8080/probeWeb. R code for CorSig is freely available for non-commercial use at http://aspendb.uga.edu/downloads.

20 September 2023 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
SCSixian Chan
Sixian Chan
BWBinghui Wu
Binghui Wu
HWHong-Qiang Wang
Hong-Qiang Wang
XZXiaolong Zhou
Xiaolong Zhou
Guodao ZhangGuodao Zhang
Guodao Zhang
GWGuoqing Wang
Guoqing Wang

3 November 2018 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
XXXin-Ping Xie
Xin-Ping Xie
YXYu-Feng Xie
Yu-Feng Xie
YLYi-Tong Liu
Yi-Tong Liu
HWHong-Qiang Wang
Hong-Qiang Wang
Identifying cancer biomarkers from transcriptomics data is of importance to cancer research. However, transcriptomics data are often complex and heterogeneous, which complicates the identification of cancer biomarkers in practice. Currently, the heterogeneity still remains a challenge for detecting subtle but consistent changes of gene expression in cancer cells. In this paper, we propose to adaptively capture the heterogeneity of expression across samples in a gene regulation space instead of in a gene expression space. Specifically, we transform gene expression profiles into gene regulation profiles and mathematically formulate gene regulation probabilities (GRPs)-based statistics for characterizing differential expression of genes between tumor and normal tissues. Finally, an unbiased estimator (aGRP) of GRPs is devised that can interrogate and adaptively capture the heterogeneity of gene expression. We also derived an asymptotical significance analysis procedure for the new statistic. Since no parameter needs to be preset, aGRP is easy and friendly to use for researchers without computer programming background. We evaluated the proposed method on both simulated data and real-world data and compared with previous methods. Experimental results demonstrated the superior performance of the proposed method in exploring the heterogeneity of expression for capturing subtle but consistent alterations of gene expression in cancer. Expression heterogeneity largely influences the performance of cancer biomarker identification from transcriptomics data. Models are needed that efficiently deal with the expression heterogeneity. The proposed method can be a standalone tool due to its capacity of adaptively capturing the sample heterogeneity and the simplicity in use. The source code of aGRP can be downloaded from https://github.com/hqwang126/aGRP .